The United States has officially lost the measles elimination status it held for more than a quarter of a century. On November 17, 2026, the Pan American Health Organization (PAHO) confirmed that sustained transmission had returned to the US, Mexico and Bolivia. The decision comes as American health authorities report thousands of infections and falling childhood vaccination coverage.

What does losing measles elimination status actually mean, how widespread is the outbreak, and can the MMR vaccine still protect people? The latest assessments from PAHO and the US Centers for Disease Control and Prevention (CDC) provide a clear answer to each question.

Why did the US lose its measles elimination status?

PAHO’s regional verification commission determined that the measles virus had circulated continuously in the United States for at least 12 months. That is the key threshold for concluding that endemic transmission has become re-established.

According to PAHO’s November 17 explanation, the relevant US outbreak began on January 20, 2025. Its continuous transmission reached the 12-month threshold on January 20, 2026. An expert commission considered epidemiological and laboratory evidence during a November 10–13 meeting, and the PAHO director accepted its conclusions.

The announcement made the formal change public on November 17, 2026.

The United States first achieved measles elimination in 2000. In public-health terminology, elimination means a country has interrupted continuous domestic transmission. Imported infections can still occur, and a short outbreak does not automatically reverse that status.

The 2026 decision means that chains of domestic transmission persisted long enough to cross the established threshold. It is a classification of the country’s disease-control situation, rather than a statement that every community has the same level of risk.

How many measles cases have been reported in the US in 2026?

The CDC reported 5,412 confirmed measles cases in the United States in 2026 as of November 12, its latest weekly national count available when the PAHO decision was announced.

The CDC’s figures also show:

  • 2,289 confirmed cases in all of 2025, making the November 2026 year-to-date total more than twice the previous full-year figure.
  • 43 newly reported outbreaks in 2026, using the CDC definition of three or more related cases.
  • 96% of confirmed 2026 cases associated with outbreaks, indicating how strongly linked transmission has shaped the national numbers.

These are confirmed cases reported to CDC, not an estimate of all infections. State and local agencies may publish newer counts before they appear in the national weekly total. The 2025 and 2026 data remain subject to revision.

PAHO has also reported a wider resurgence across the Americas. Its November 17 announcement said that Bolivia and Mexico, alongside the US, had lost their respective elimination status after sustained transmission.

Why are measles outbreaks spreading again?

Measles is exceptionally contagious. The virus spreads through the air, and exposure can occur when an infectious person has been in an enclosed space. A population with substantial gaps in immunity gives the virus more opportunities to move between households, schools and communities.

Vaccination coverage among US kindergarten pupils fell from 95.2% in the 2019–2020 school year to 92.4% in 2025–2026, according to CDC figures published in November 2026.

That national percentage can conceal much lower protection in particular communities. CDC estimates that approximately 280,000 kindergarten pupils were at risk during the 2025–2026 school year because of gaps in MMR coverage.

The agency also identifies international measles activity as a factor: travel can bring the virus into the country, where it may spread if enough people lack protection.

A loss of elimination status is therefore connected to sustained chains of transmission and immunity gaps, not to a single infected traveller or one local outbreak.

How effective is the MMR vaccine against measles?

Two doses of the measles, mumps and rubella (MMR) vaccine are approximately 97% effective at preventing measles; one dose is approximately 93% effective, according to CDC guidance.

Those percentages describe protection against disease, rather than a guarantee that infection is impossible in every individual. Breakthrough infections can happen, particularly during intense outbreaks, but they remain uncommon among vaccinated people.

The CDC says that maintaining vaccination coverage above roughly 95% in a community helps protect people through population immunity. That is especially important for those who cannot receive an MMR vaccine for medical reasons.

Routine vaccine eligibility and scheduling depend on factors including age, medical history and possible exposure. People uncertain about their vaccination record or an outbreak-related recommendation should consult a qualified healthcare professional or local public-health department.

Does the announcement change the risk for travellers?

The PAHO decision does not, by itself, create a universal travel ban or a new entry requirement. It does highlight why travellers should check measles vaccination recommendations before trips and monitor health advisories issued for their destination.

A person who suspects measles exposure, or develops symptoms consistent with measles, should seek guidance from a healthcare provider and contact the facility before arriving so precautions can be arranged. Measles may pose particular risks to infants and people with compromised immune systems.

For current location-specific information, the CDC points the public to state and local health departments, whose outbreak reports may be more up to date than national surveillance totals.

Can the United States regain measles elimination status?

Yes. Regaining verification requires interrupting endemic transmission for at least 12 months, together with stronger vaccination, surveillance and outbreak-response measures subject to review.

In its November 17 statement, the CDC said it would work with public-health agencies and partners to expand MMR vaccine access, identify communities at increased risk and improve outbreak detection. PAHO has called for similar action throughout the Americas.

The designation can be restored, but that depends on documented control of sustained transmission, not on a change in the name of the disease or a one-time decline in reported cases.

What the measles decision means now

The central fact is that measles has resumed sustained domestic transmission in the United States. PAHO made that finding public on November 17, 2026, while CDC surveillance had already recorded 5,412 confirmed cases for the year as of November 12.

The CDC’s 97% effectiveness estimate for two MMR doses also provides the clearest answer to the question of prevention. The next test for public-health agencies is whether vaccination gaps can be closed and transmission interrupted for long enough to regain elimination status.

Case counts and outbreak assessments reflect official information available on November 18, 2026 and may change as surveillance data are updated.